Loading...
Pacific Biosciences of California, Inc.
PACB•NASDAQ
Healthcare
Medical - Devices
$1.54
$0.00(0.00%)
Pacific Biosciences of California, Inc. (PACB) Financial Performance & Income Statement Overview
Review Pacific Biosciences of California, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-23.19%
↓ 23.19%
Operating Income Growth
-6.55%
↓ 6.55%
Net Income Growth
-1.02%
↓ 1.02%
Operating Cash Flow Growth
20.49%
↑ 20.49%
Operating Margin
-519.00%
↓ 519.000%
Gross Margin
16.17%
↑ 16.17%
Net Profit Margin
-431.71%
↓ 431.71%
ROE
-170.40%
↓ 170.40%
ROIC
-99.57%
↓ 99.57%
Pacific Biosciences of California, Inc. (PACB) Income Statement & Financial Overview
Review Pacific Biosciences of California, Inc.'s (PACB) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $39.22M | $39.97M | $36.01M | $38.81M |
| Cost of Revenue | $29.17M | $29.96M | $30.07M | $34.38M |
| Gross Profit | $10.06M | $10.004M | $5.94M | $4.43M |
| Gross Profit Ratio | $0.26 | $0.25 | $0.16 | $0.11 |
| R&D Expenses | $27.47M | $25.52M | $38.48M | $43.45M |
| SG&A Expenses | $41.64M | $43.75M | $45.88M | $42.41M |
| Operating Expenses | $132.72M | $69.26M | $68.30M | $85.86M |
| Total Costs & Expenses | $161.89M | $99.22M | $118.66M | $120.24M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.76M | $3.54M | $3.54M | $3.58M |
| Depreciation & Amortization | $10.95M | $16.10M | $14.29M | $12.01M |
| EBITDA | $17.59M | -$41.09M | -$155.49M | -$62.59M |
| EBITDA Ratio | $0.45 | -$1.03 | -$4.32 | -$1.61 |
| Operating Income | -$122.66M | -$59.26M | -$145.77M | -$81.43M |
| Operating Income Ratio | -$3.13 | -$1.48 | -$4.05 | -$2.10 |
| Other Income/Expenses (Net) | $125.35M | -$1.47M | -$27.55M | $3.18M |
| Income Before Tax | $2.69M | -$60.73M | -$173.32M | -$78.18M |
| Income Before Tax Ratio | $0.07 | -$1.52 | -$4.81 | -$2.01 |
| Income Tax Expense | $316000.00 | $0.00 | $0.00 | $11.97M |
| Net Income | $2.37M | -$60.73M | -$173.32M | -$78.18M |
| Net Income Ratio | $0.06 | -$1.52 | -$4.81 | -$2.01 |
| EPS | $0.008 | -$0.22 | -$0.64 | -$0.29 |
| Diluted EPS | $0.008 | -$0.22 | -$0.64 | -$0.29 |
| Weighted Avg Shares Outstanding | $283.00M | $272.92M | $272.38M | $269.58M |
| Weighted Avg Shares Outstanding (Diluted) | $306.89M | $272.92M | $272.38M | $269.58M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan